Inventor · disambiguated record
Christof Niehrs
Also filed as: NIEHRS CHRISTOF
15 granted patents·13 pending applications·101 citations·filing 1998–2020
91Inventor score
Files withDEUTSCHES KREBSFORSCH16NIEHRS CHRISTOF9DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS2RAWADI GEORGES1
Top patents by PatentIndex Score
28 records- 0189US8088374B2Methods for inhibition of angiogenesis and vasculogenesis via rspondin antagonistsNIEHRS CHRISTOF·Filed 2007·Granted Jan 3, 2012·17 cites·5 claims
- 0286US6844422B1Inhibitor protein of the wnt signal pathwayDEUTSCHES KREBSFORSCH·Filed 1998·Granted Jan 18, 2005·66 cites·6 claims
- 0380US7947462B2Methods for identifying Kremen polypeptide binding partnersDEUTSCHES KREBSFORSCH·Filed 2008·Granted May 24, 2011·5 cites·10 claims
- 0480US7138508B2Inhibitor protein of the wnt signal pathwayDEUTSCHES KREBSFORSCH·Filed 2004·Granted Nov 21, 2006·12 cites·5 claims
- 0570US2019194306A1Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (r-spondins) and/or wntDEUTSCHES KREBSFORSCH·Filed 2018·Application pending·0 cites
- 0668US10538563B2Rspondins as modulators of angiogenesis and vasculogenesisDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2019·Granted Jan 21, 2020·0 cites·3 claims
- 0767US8227200B2Methods for identifying kremen polypeptide binding partnersNIEHRS CHRISTOF·Filed 2011·Granted Jul 24, 2012·1 cites·10 claims
- 0865US9226963B2Antagonist anti-Rspondin3 antibodiesDEUTSCHES KREBSFORSCH·Filed 2014·Granted Jan 5, 2016·0 cites·4 claims
- 0965US8951745B2Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-Spondins) and/or WntDEUTSCHES KREBSFORSCH·Filed 2014·Granted Feb 10, 2015·0 cites·14 claims
- 1065US8921056B2Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-Spondins) and/or WntDEUTSCHES KREBSFORSCH·Filed 2014·Granted Dec 30, 2014·0 cites·14 claims
- 1162US8926970B2Rspondin antibodies as inhibiting factors of angiogenesis and vaculogenesisDEUTSCHES KREBSFORSCH·Filed 2013·Granted Jan 6, 2015·0 cites·11 claims
- 1261US8536311B2Inhibitor protein of the wnt signal pathwayNIEHRS CHRISTOF·Filed 2006·Granted Sep 17, 2013·0 cites·21 claims
- 1361US2016376349A1Compositions For diagnosis and Therapy of diseases associated with aberrant expression of Futrins (R-Spondins) and/or WntDEUTSCHES KREBSFORSCH·Filed 2015·Application pending·0 cites
- 1460US2013337533A1Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondins) and/or WntDEUTSCHES KREBSFORSCH·Filed 2013·Application pending·0 cites
- 1560US2014134703A1Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondins) and/or WntDEUTSCHES KREBSFORSCH·Filed 2013·Application pending·0 cites
- 1660US2014186917A1Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondins) and/or WntDEUTSCHES KREBSFORSCH·Filed 2013·Application pending·0 cites
- 1758US10273276B2Rspondins as modulators of angiogenesis and vasculogenesisDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2015·Granted Apr 30, 2019·0 cites·2 claims
- 1857US8580736B2Rspondin polypeptides as promoting factors of angiogenesis and vasculogenesisNIEHRS CHRISTOF·Filed 2011·Granted Nov 12, 2013·0 cites·5 claims
- 1956US8461309B2Inhibitor protein of the wnt signal pathwayNIEHRS CHRISTOF·Filed 2011·Granted Jun 11, 2013·0 cites·5 claims
- 2052US9081011B2Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-spondins) and/or WntNIEHRS CHRISTOF·Filed 2004·Granted Jul 14, 2015·0 cites·14 claims
- 2151US2013302339A1Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and or wntNIEHRS CHRISTOF·Filed 2012·Application pending·0 cites
- 2251US2025346890A1Leukemia treatmentDEUTSCHES KREBSFORSCH·Filed 2020·Application pending·0 cites
- 2349US2005244826A1Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or wntNIEHRS CHRISTOF·Filed 2003·Application pending·0 cites
- 2449US2017153246A1Receptors of rspo2 and rspo3DEUTSCHES KREBSFORSCH·Filed 2017·Application pending·0 cites
- 2546US2012263730A1Receptors of rspo2 and rspo3NIEHRS CHRISTOF·Filed 2010·Application pending·0 cites
- 2643US2015362489A1Receptors of rspo2 and rspo3DEUTSCHES KREBSFORSCH·Filed 2015·Application pending·0 cites
- 2736US2019321311A1Cancer Treatment by Simultaneous Targeting Energy Metabolism and Intracellular pHDEUTSCHES KREBSFORSCH·Filed 2017·Application pending·0 cites
- 2834US2012039912A1Rspondin-3 inhibition in bone disordersRAWADI GEORGES·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christof Niehrs files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →